On July 20, Robert Califf, the head of the Food and Drug Administration (FDA), announced that he would commission external experts to conduct “a comprehensive evaluation” of the agency’s food and nicotine divisions.
The move comes after the FDA’s Center for Tobacco Products (CTP) has been under relentless fire over its handling of its PMTA authorization process for vaping products—including a high-profile apparent reversal over Juul earlier this month.
Califf, however, painted a rosy picture of a workforce eager to be rigorously reviewed.
“I have discussed this evaluation with the relevant leadership of these centers and offices, all of whom welcome the opportunity to work towards organizational excellence,” he said in a press release.
Alex Norcia – Filter – 2022-07-21
Want More Investigative Content?
